Articles by Andrew Zolopa

Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy: A Randomized Phase 2 Study

Sax, Paul E.; Zolopa, Andrew; Brar, Indira; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1):52-58, September 1st, 2014.

Regulatory T Cells and the Risk of CMV End-Organ Disease in Patients With AIDS

Weinberg, Adriana; Bosch, Ronald; Bennett, Kara; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(1):25-32, May 1st, 2014.

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF ...

Wohl, David A.; Cohen, Calvin; Gallant, Joel E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e118-e120, March 1st, 2014.

A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil...

Zolopa, Andrew; Sax, Paul E.; DeJesus, Edwin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1):96-100, May 1st, 2013.

Association of HIV Infection, Demographic and Cardiovascular Risk Factors With All-Cause Mortality in the Recent HAART Era

Cockerham, Leslie; Scherzer, Rebecca; Zolopa, Andrew; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(1):102-106, January 2010.